EGFR and COVID-19: Surprisingly, several research studies have pointed out that inhibition of several RTKs (e.g. epidermal growth factor receptor (EGFR), insulin-like growth factor (IGF)-1R) decreases the risk of death in COVID-19 patients [18,19].